The utility of transoral robotic surgery for oropharyngeal squamous cell carcinoma: functional and perioperative outcomes
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20262358Keywords:
Transoral robotic surgery, Oropharyngeal squamous cell carcinoma, Head and neck cancer of unknown primary, Oropharyngeal functionAbstract
Background: To evaluate the functional recovery, oncologic and perioperative outcomes of patients undergoing transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC).
Methods: A retrospective cohort study of 103 patients who underwent TORS between 2015 and 2024 was conducted. Patients were stratified into diagnostic-TORS (patients with head and neck cancer of unknown primary origin (HNCUP), n=28) and therapeutic-TORS groups (resection of T1-T2 OPSCC, n=75). The primary outcomes were oropharyngeal function post-TORS. Secondary outcomes related to HNCUP detection, treatment de-intensification, overall survival (OS), and surgical complications.
Results: Immediate oral intake was observed in 90.3% of patients. No patients required long-term gastrostomy feeding. A progressive improvement in diet and fluid levels was observed, with 88.9% of patients achieving a normal diet within 12 months. At 12 months post-TORS, 90.3% of patients recovered their premorbid speech level. HNCUP identification rate was 42.9% with diagnostic-TORS. Five-year OS was 89% (95% CI, 78-94%). Tumours with positive p16 status had significantly improved OS (94% vs. 63%, p=0.001). Although margin status did not demonstrate statistically significant differences in OS (p=0.313), all patients requiring re-excision achieved clear margins, facilitating treatment de-intensification. Post-operative bleeding was observed in 6.8% of patients, with a peri-operative mortality rate of 1.9%.
Conclusions: TORS is effective in oropharyngeal cancer management, delivering excellent functional and survival outcomes. Our study supports the role of TORS in treatment de-intensification. The risk of significant haemorrhagic complications necessitates rigorous perioperative protocols.
References
Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26(21):3582-9.
Hedayat F, Jerry Htwe KK, Vassiliou LV, Panayiotis K. Morbidity related to the lip-split mandibulotomy approach: a systematic and narrative review. Brit J Oral Maxillofac Surg. 2022;60(4):430-36.
Kim JW, Koo BS, Kim HS, Park JH, Park JJ, Park JO, et al. Quality of Life in Oropharyngeal Cancer: A Retrospective Analysis of Patient Characteristics and Treatment Modalities. Ann Surg Oncol. 2025;32(13):9928-41.
Arora A, Brunet A, Oikonomou G, Tornari C, Faulkner J, Jeyarajah J, et al. Establishing and integrating a transoral robotic surgery programme into routine oncological management of head and neck cancer-a UK perspective-ERRATUM. J Laryngol Otol. 2023;137(1):118.
Genden EM, O'Malley BW Jr, Weinstein GS, Stucken CL, Selber JC, Rinaldo A, et al. Transoral robotic surgery: role in the management of upper aerodigestive tract tumors. Head Neck. 2012;34(6):886-93.
Pinkiewicz M, Dorobisz K, Zatoński T. A Systematic Review of Cancer of Unknown Primary in the Head and Neck Region. Cancer Manag Res. 2021;13:7235-41.
Maghami E, Ismaila N, Alvarez A, Rebecca C, Umamaheswar D, Jessica G, et al. Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline. J Clin Oncol. 2020;38(22):2570-96.
de Almeida JR, Martino R, Hosni A, David PG, Scott VB, Douglas BC, et al. Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial. JAMA Otolaryngol Head Neck Surg. 2024;150(6):463-71.
Amin MB, Greene FL, Edge SB, Carolyn CC, Jeffrey EG, Robert KB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin. 2017;67(2):93-9.
Cichero JA, Lam P, Steele CM, Ben H, Jianshe C, Roberto OD, et al. Development of International Terminology and Definitions for Texture-Modified Foods and Thickened Fluids Used in Dysphagia Management: The IDDSI Framework. Dysphagia. 2017;32(2):293-314.
List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer. 1996;77(11):2294-301.
Cheung MH, Kim CH, Nguyen SA, Lauren W, Alexandra K, Michael B, et al. Oncologic Outcomes of Transoral Robotic Surgery in HPV-Associated OPSCC: A Systematic Review and Meta-Analysis. Otolaryngol Head Neck Surg. 2026;174(2):334-46.
Amin DR, Philips R, Bertoni DG, Mastrolonardo EV, Campbell DJ, Agarwal AM, et al. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2023;149(11):980-86.
Lazarus CL, Ganz C, Ru M, Miles BA, Kotz T, Chai RL, et al. Prospective instrumental evaluation of swallowing, tongue function, and QOL measures following transoral robotic surgery alone without adjuvant therapy. Head Neck. 2019;41(2):322-8.
Chung TK, Rosenthal EL, Magnuson JS, Carroll WR. Transoral robotic surgery for oropharyngeal and tongue cancer in the United States. Laryngoscope. 2015;125(1):140-5.
van Weert S, Rijken JA, Plantone F, Elisabeth B, Marije RV, Birgit IL-W, et al. A systematic review on Transoral robotic surgery (TORS) for carcinoma of unknown primary origin: Has tongue base mucosectomy become indispensable? Clin Otolaryngol. 2020;45(5):732-8.
Farooq S, Khandavilli S, Dretzke J, David M, Nankivell PC, Sharma N, et al. Transoral tongue base mucosectomy for the identification of the primary site in the work-up of cancers of unknown origin: Systematic review and meta-analysis. Oral Oncol. 2019;91:97-106.
Ferris RL, Flamand Y, Weinstein GS, Shuli L, Harry Q, Ranee M, et al. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). J Clin Oncol. 2022;40(2):138-49.
Grewal AS, Rajasekaran K, Cannady SB, Chalian AA, Ghiam AF, Lin A, et al. Pharyngeal‐sparing radiation for head and neck carcinoma of unknown primary following TORS assisted work‐up. The Laryngoscope. 2020;130(3):691-7.
Owadally W, Hurt C, Timmins H, Emma P, Sarah T, Joanne P, et al. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 2015;15:602.
National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, 2024. Available at: https://www.nccn.org. Accessed on 02 February 2026.
Tucker A, Bollig CA. A National Analysis of Microscopic Positive Margins in Oropharyngeal Cancer Patients Undergoing Transoral Robotic Surgery. Otolaryngol Head Neck Surg. 2026;174(3):756-64.
Hanna J, Morse E, Brauer PR, Benjamin J, Saral M. Positive margin rates and predictors in transoral robotic surgery after federal approval: A national quality study. Head Neck. 2019;41(9):3064-72.
Kejner A, Gentile C, Porterfield Z, William RC, Erin PB. Positive Deep Initial Incision Margin Affects Outcomes in TORS for HPV+ Oropharynx Cancer. Laryngoscope 2023;133(5):1132-37.
Calcano GA, Rourk KS, Routman DM, O'Byrne JJ, Chintakuntlawar AV, Garcia JJ, et al. The Impact of “Close Margins” in HPV-Associated Oropharyngeal Squamous Cell Carcinoma Treated With TORS. Otolaryngol Head Neck Surg. 2025;172(4):1291-9.
Karadaghy OA, Wu MP, Farrokhian N, Maria A, Nadia LS, Rohith B, et al. Impact of Margins on Outcomes in HPV-Related Oropharyngeal Squamous Cell Carcinoma Treated With Surgery Only. Otolaryngol Head Neck Surg. 2025;173(1):106-14.
Pinhorn C, Stewart R, Payne T, Daniel E, Singh-Dehal Y, Muralitharan M, et al. Haemorrhage following transoral robotic surgery in head and neck cancer. J Robotic Surg. 2025;20(1):133.
Davies JC, Husain Z, Day TA, Evan MG, Antoine E. Perioperative Mortality Risk in Patients Undergoing Transoral Robotic Surgery for T1-T2 Oropharyngeal Squamous Cell Carcinoma: A National Cancer Database Study. Front Oncol. 2021;11:808465.
Topf MC, de Almeida JR, Holsinger FC. Should Transcervical Arterial Ligation Be Performed During Transoral Robotic Surgery? Laryngoscope. 2025;135(11):3974-5.
Stokes W, Ramadan J, Lawson G, Ferris FRL, Holsinger FC, Turner MT. Bleeding Complications After Transoral Robotic Surgery: A Meta-Analysis and Systematic Review. Laryngoscope. 2021;131(1):95-105.
Downloads
Published
How to Cite
Issue
Section
